Abstract
Previously we have shown that collagen I enhances the maturation and function of dendritic cells (DCs). Inflammatory mediators such as tumour necrosis factor (TNF)-α, interleukin (IL)-1β and lipopolysaccharide (LPS) are also known to activate DCs. Here we investigated the involvement of TNF-α on the collagen I-induced DCs activation. TNF-a neutralization inhibited collagen I-induced IL-12 secretions by DCs. Additionally, we observed suppression of collagen I-induced costimulatory molecules expression along with down-regulation of genes involved in DCs activation pathway. Furthermore, TNF-α inhibition upon collagen Istimulation up-regulated the expression of interferon regulatory transcription factor IRF4, when compared to collagen I only treated cells. Collectively, our data demonstrate that collagen I induce TNF-α production, which is crucial for the activation and function of DCs, through down-regulation of IRF4, and implicates the importance in development of anti- TNF-α therapeutics for several inflammatory diseases.
Similar content being viewed by others
Abbreviations
- DC:
-
dendritic cells
- GMCSF:
-
granulocyte-macrophage colony stimulating factor
- IRF4 :
-
interferon regulatory factor 4
- IL:
-
interleukin
- ECM:
-
major extracellular matrix
- MHC:
-
major histocompatibility complex
- Th1:
-
T-helper type 1
References
Akbari M, Honma K, Kimura D, Miyakoda M, Kimura K, Matsuyama T and Yui K 2014 IRF4 in dendritic cells inhibit IL-12 production and controls Th1 immune responses against Leishmania major. J. Immunol. 192 2271–2279
Besin G, Gaudreau S, Dumont-Blanchette E, Menard M, Guindi C, Dupuis G and Amrani A 2011 IFN regularoty factors 4 and 8 expression in the NOD mouse. Clin. Dev. Immunol. 2011 doi:10.1155/2011/374859
Boks MA, Kager-Groenland JR, Mousset CM, van Ham SM and Ten Brinke A 2014 Inhibition of TNF receptor signaling by anti-TNFα biologicals primes naïve CD4(+) T cells towards IL-10(+) T cells with a regulatory phenotype and function. Clin. Immunol. 151 136–145
Brand U, Bellinghausen I, Enk AH, Jonuleit H, Becker D, Knop J and Saloga J 1998 Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur. J. Immunol. 28 1673–1680
Feldmann M and Steinman L 2005 Design of effective immunotherapy for human autoimmunity. Nature 435 612–619
Hu Y, Park-Min KH, Yarilina A and Ivashkiv LB 2008 Regulation of STAT pathways and IRF1 during human dendritic cell maturation by TNF-alpha and PGE2. J. Leukoc. Biol. 84 1353–1360
Iwasaki A 2007 Mucosal dendritic cells. Annu. Rev. Immunol. 25 381–418
Kanada S, Nishiyama C, Nakano N, Suzuki R, Maeda K, Hara M, Kitamura N, Ogawa H, et al. 2011 Critical role of transcription factor PU.1 in the expression of CD80 and CD86 on dendritic cells. Blood 117 2211–2222
Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K and Udalova IA 2010 IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood 115 4421–4430
Lee JE, Kang CS, Guan XY, Kim BT, Kim SH, Lee YM, Moon WS and Kim DK 2007 Discoidin domain receptor 2 is involved in the activation of bone marrow-derived dendritic cells caused by type I collagen. Biochem. Biophys. Res. Commun. 352 244–250
Mahnke K, Bhardwaj RS, Luger TA, Schwarz T and Grabbe S 1996 Interaction of murine dendritic cells with collagen up-regulates allostimulatory capacity, surface expression of heat stable antigen, and release of cytokines. J. Leukoc. Biol. 60 465–472
Marecki S, Atchison ML and Fenton MJ 2009 Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages. J. Immunol. 163 2713–2722
Martin AP, Alexander-Brett JM, Canasto-Chibuque C, Garin A, Bromberg JS, Fremont DH and Lira SA 2007 The chemokines binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J. Immunol. 178 4623–4631
Njau F, Wittkop U, Rohde M, Haller H, Klos A and Wagner AD 2009 In vitro neutralization of tumor necrosis factor-alpha during Chlamydia pneumoniae infection impairs dendritic cells maturation/function and increases chlamydial progeny. FEMS. Immunol. Med. Microbiol. 55 215–225
Pan H, O'Brien TF, Wright G, Yang J, Shin J, Wright KL and Zhong XP 2013 Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA. J. Immunol. 191 699–707
Poudel B, Yoon DS, Lee JH, Lee YM and Kim DK 2012 Collagen I enhances functional activities of human monocyte-derived dendritic cells via discoidin domain receptor 2. Cell. Immunol. 278 95–102
Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF and Austyn JM 1995 Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181 2237–2247
Santiago-Schwarz F, McCarthy M, Tucci J and Carsons SE 1998 Neutralization of tumor necrosis factor activity shortly after the onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway. Blood 92 745–755
Seth S, Oberdörfer L, Hyde R, Hoff K, Thies V, Worbs T, Schmitz S and Förster R 2011 CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions. J. Immunol. 186 3364–3372
Steinman RM, Hawiger D and Nussenzweig MC 2003 Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 685–711
Suzuki S, Honma K, Matsuyama T, Suzuki K, Toriyama K, Akitoyo I, Yamamoto K, Suematsu T, et al. 2004 Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development. Proc. Natl. Acad. Sci. USA 101 8981–8986
Tamura T, Tailor P, Yamaoka K, Kong HJ, Tsujimura H, O'Shea JJ, Singh H and Ozato K 2005 IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174 2573–2581
Thomas R, Davis LS and Lipsky PE 1994 Rhematoid synovium is enriched in mature antigen-presenting dendritic cells. J. Immunol. 152 2613–2623
van Lieshout AW, Barrera P, Smeets RL, Pesman GJ, van Riel PL, van den Berg WB and Radstake TR 2005 Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis. Ann. Rheum. Dis. 64 408–414
van Vollenhoven RF 2009 Treatment of rheumatoid arthritis: state of the art 2009. Nat. Rev. Rheumatol. 5 531–541
Vander Lugt B, Khan AA, Hackney JH, Agrawal S, Lesch J, Zhou M, Lee WP, Park S, et al. 2014 Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat. Immunol. 15 161–167
Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, Zimmermann VS, Davoust J, et al. 1997 Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185 317–328
Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, et al. 2008 TNF-alpha blockade in human diseases: mechanisms and future directions. Clin. Immunol. 126 121–136
Xu D, Meyer F, Ehlers E, Blasnitz L and Zhang L 2011 Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation. J. Biol. Chem. 286 18261–18267
Acknowledgements
This study was supported by grants from Wonkwang University (2013).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Corresponding editor: Satyajit Rath
[Poudel B, Ki H-H, Lee Y-M and Kim D-K 2015 Collagen I-induced dendritic cells activation is regulated by TNF-α production through down-regulation of IRF4. J. Biosci. 40 1–8] DOI 10.1007/s12038-015-9507-7
Rights and permissions
About this article
Cite this article
Poudel, B., Ki, HH., Lee, YM. et al. Collagen I-induced dendritic cells activation is regulated by TNF-α production through down-regulation of IRF4 . J Biosci 40, 71–78 (2015). https://doi.org/10.1007/s12038-015-9507-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-015-9507-7